Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618316.RAGteq-v2YYVG8dSoY3vS7Wg647YsEj6pKX3kMEW0xPSU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618316.RAGteq-v2YYVG8dSoY3vS7Wg647YsEj6pKX3kMEW0xPSU130_assertion type Assertion NP618316.RAGteq-v2YYVG8dSoY3vS7Wg647YsEj6pKX3kMEW0xPSU130_head.
- NP618316.RAGteq-v2YYVG8dSoY3vS7Wg647YsEj6pKX3kMEW0xPSU130_assertion description "[PTPN12 interacts with the same T cell activation accessory molecules, Grb2 and Csk kinase, as the Graves' disease (GD) associated PTPN22 encoded lymphoid tyrosine phosphatase (LYP) molecule and also plays a key role in T cell receptor signalling, leading to the hypothesis that it too may be involved in GD susceptibility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618316.RAGteq-v2YYVG8dSoY3vS7Wg647YsEj6pKX3kMEW0xPSU130_provenance.
- NP618316.RAGteq-v2YYVG8dSoY3vS7Wg647YsEj6pKX3kMEW0xPSU130_assertion evidence source_evidence_literature NP618316.RAGteq-v2YYVG8dSoY3vS7Wg647YsEj6pKX3kMEW0xPSU130_provenance.
- NP618316.RAGteq-v2YYVG8dSoY3vS7Wg647YsEj6pKX3kMEW0xPSU130_assertion SIO_000772 17608818 NP618316.RAGteq-v2YYVG8dSoY3vS7Wg647YsEj6pKX3kMEW0xPSU130_provenance.
- NP618316.RAGteq-v2YYVG8dSoY3vS7Wg647YsEj6pKX3kMEW0xPSU130_assertion wasDerivedFrom befree-2016 NP618316.RAGteq-v2YYVG8dSoY3vS7Wg647YsEj6pKX3kMEW0xPSU130_provenance.
- NP618316.RAGteq-v2YYVG8dSoY3vS7Wg647YsEj6pKX3kMEW0xPSU130_assertion wasGeneratedBy ECO_0000203 NP618316.RAGteq-v2YYVG8dSoY3vS7Wg647YsEj6pKX3kMEW0xPSU130_provenance.